ORIGINAL PAPER
Knowledge of cervical cancer risk factors among students at the Jan Kochanowski University in Kielce
More details
Hide details
Publication date: 2013-10-25
Medical Studies 2013;29(3):255-259
KEYWORDS
ABSTRACT
Introduction: Cervical cancer is the third most common malignant tumour in women. As far as we know today, the main cause of cervical cancer is human papilloma virus (HPV) infection with high grade oncogenic HPV genotypes, as well as co-occurrence of other factors predisposing women to cervical cancer. According to the WHO, the factors include smoking, multiple sexual partners, low socioeconomic status, herpes simplex virus (HSV) co-infection, human immunodeficiency virus infection, and antioxidant and vitamin insufficiency in the diet.
Aim of the research: To assess the knowledge of cervical cancer among young women.
Material and methods: The survey was carried out in 2010–2012 in a group of 149 female students at the age of 20 ±1 at the Jan Kochanowski Memorial University, Kielce prior to gynaecology, pathology and oncology classes. The questionnaire survey included closed multiple choice questions. The statistical analyais was conducted by means of PQStat ver. 1.4.4 software using ANOVA and Fisher tests.
Results and conclusions: The obtained results show that the 94% of the surveyed people are familiar with the impact of HPV infection, but knowledge of accessory risk factors of cervical cancer is at low level. The study revealed that smoking is regarded as another risk factor by 13% of the surveyed people, HSV infection by 9%, multiple sex partners by 21%, and low hygiene level by 25%. Our examination revealed differences regarding the knowledge and available information sources by the respondents’ place of residence. Knowledge level of cervical cancer development depends on the place of residence and reaches the highest level in towns with over 20,000 inhabitants. The main source of information on cervical cancer risk factors is Internet and peer opinions.
REFERENCES (15)
1.
Hussain S, Bharadwaj M, Nasare V, et al. Human papillomavirus infection among young adolescents in India: impact of vaccination. J Med Virol 2012; 84: 298–305.
2.
Silva J, Ribeiro J, Sousa H, et al. Oncogenic HPV types infection in adolescents and university women from North Portugal: from self-sampling to cancer prevention. J Oncol 2011; 2011: 953469.
3.
Lazcano-Ponce E, Lorincz AT, Cruz-Valdez, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011; 378: 1868–1873.
4.
Underwood JM, Rim SH, Fairley TL, et al. Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008. Cancer Causes Control 2012, 23: 1009–1016.
5.
Spaczyński M, Karowicz-Bilinska A, Rokita W, et al. Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009 [Polish]. Ginekol Pol 2010; 81: 655–663.
6.
Knapp P, Zbroch T, Knapp P. The use of interactive medical data transfer to increase effectiveness of a mass screening program. Ginekol Pol 2004; 75: 896–903.
7.
Centers for Disease Control and Prevention (CDC). Cancer screening – United States, 2010. MMWR Morb Mortal Wkly Rep 2012; 61: 41–45.
8.
Kulasingam SL, Havrilesky L, Ghebre R, et al. Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.
9.
Albrow R, Kitchener H, Gupta N, et al. Cervical screening in England: the past, present, and future. Cancer Cytopathol 2012; 120: 87–96.
10.
National Comprehensive Cancer Network. Cancer Epide¬miology and Prevention Department at Cancer Centre and Oncology Institute in Warsaw, Poland.
11.
Burger EA, Ortendahl JD, Sy S, et al. Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway. Br J Cancer 2012; 106: 1571–1578.
12.
Donati S, Giambi C, Declich S, et al. Knowledge, attitude and practice in primary and secondary cervical cancer prevention among young adult Italian women. Vaccine 2012; 30: 2075–2082.
13.
Papa D, Moore Simas TA, Reynolds M, et al. Assessing the role of education in women’s knowledge and acceptance of adjunct high-risk human Papillomavirus testing for cervical cancer screening. J Low Genit Tract Dis 2009; 13: 66–71.
14.
Klug SJ, Hetzer M, Blettner M. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors. Eur J Public Health 2005; 15: 70–77.
15.
Kivistik A, Lang K, Baili P, et al. Women’s knowledge about cervical cancer risk factors, screening, and reasons for non-participation in cervical cancer screening programme in Estonia. BMC Womens Health 2011; 11: 43.